HLSQ — Tessera Defense and Homeland Security Share News
0.000.00%
Last trade - 00:00Brief: Biomx - Announces One-For-Ten Reverse Stock Split Of Common Stock - SEC Filing
Brief: Biomx And Water.Io Agree To Updated Zorronet Acquisition Terms
Brief: BiomX - May Offer And Sell Up To $9.10 Million Of Common Stock Through Wainwright - SEC Filing
Brief: Biomx Provides Update On Defense Technology Portfolio And Growth Strategy
Brief: Biomx Inc - Buys 100% Of Zorronet From Water Io - SEC Filing
Brief: BiomX Obtains Option To Acquire Control Of Israeli Laser-Radar Counter-Drone System
Brief: Biomx Adds Former Mossad Deputy To Advisory Board
Brief: Biomx Inc - Jonathan Solomon Resigns As CEO And Board Member Effective March 4, 2026 - SEC Filing
Brief: BiomX Says Unaware of Any Undisclosed Developments Amid Unusual Stock Trading
Brief: BiomX Announces Discontinuation Of Phase 2b Bx004 Trial Following Internal Review
Brief: BiomX Provides A Program Update And Announces New FDA Feedback Potentially Expanding BX004 Development Pathways
BiomX falls after US FDA places genetic disorder treatment study on hold
Brief: BiomX Reports Second Quarter 2025 Financial Results
Brief: Biomx Reports First Quarter 2025 Financial Results
Brief: BiomX Announces Positive Topline Results From Phase 2 Trial Evaluating Bx211 For The Treatment Of Diabetic Foot Osteomyelitis (DFO)
Brief: BiomX Announces Mandatory Unit Separation
Brief: Biomx To Provide Latest Update On Positive Phase 1B/2A Clinical Trial Data For Bx004 At North American Cystic Fibrosis Conference
Brief: Biomx Inc. Receives Notice Of Non-Compliance With NYSE American Continued Listing Standards
Brief: BiomX Reports First Quarter 2024 Financial Results And Provides Business And Program Updates